RSV immunization regimen
US11813323B2 · kind B2 · utility
0Cited by
8References
29Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 24, 2022 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Jun 24, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/18634
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to an immunization regimen whereby an infant is protected against respiratory syncytial virus (RSV) through administration of a first anti-RSV immune response inducing composition to his or her mother during pregnancy, followed by administration of a second anti-RSV immune response inducing composition to the infant after birth.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.